Serial Number 97494522
Registration 7127089
700

Registration Progress

Application Filed
Jul 8, 2022
Under Examination
Approved for Publication
May 16, 2023
Published for Opposition
May 16, 2023
Registered
Aug 1, 2023

Trademark Image

Basic Information

Serial Number
97494522
Registration Number
7127089
Filing Date
July 8, 2022
Registration Date
August 1, 2023
Published for Opposition
May 16, 2023
Drawing Code
2000

Status Summary

Current Status
Active
Status Code
700
Status Date
Aug 1, 2023
Registration
Registered
Classes
005

Rights Holder

Travere Therapeutics, Inc.

03
Address
Suite 300
3611 Valley Centre Drive
San Diego, CA 92130

Ownership History

Travere Therapeutics, Inc.

Original Applicant
03
San Diego, CA

Travere Therapeutics, Inc.

Owner at Publication
03
San Diego, CA

Travere Therapeutics, Inc.

Original Registrant
03
San Diego, CA

Legal Representation

Attorney
Jared M. Barrett

USPTO Deadlines

Next Deadline
1465 days remaining
Section 8 (6-Year) Declaration Due (Based on registration date 2023-08-01)
Due Date
August 01, 2029
Grace Period Ends
February 01, 2030
Additional deadlines exist. Contact your attorney for complete deadline information.

Application History

15 events
Date Code Type Description Documents
Aug 1, 2023 R.PR A REGISTERED-PRINCIPAL REGISTER Loading...
Aug 1, 2023 NRCC E NOTICE OF REGISTRATION CONFIRMATION EMAILED Loading...
May 16, 2023 PUBO A PUBLISHED FOR OPPOSITION Loading...
May 16, 2023 NPUB E OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED Loading...
Apr 26, 2023 NONP E NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED Loading...
Apr 13, 2023 AAUA E NOTICE OF ACCEPTANCE OF AMENDMENT TO ALLEGE USE E-MAILED Loading...
Apr 12, 2023 IUAA P USE AMENDMENT ACCEPTED Loading...
Apr 12, 2023 CNSA O APPROVED FOR PUB - PRINCIPAL REGISTER Loading...
Apr 4, 2023 DOCK D ASSIGNED TO EXAMINER Loading...
Feb 23, 2023 IUAF S USE AMENDMENT FILED Loading...
Feb 23, 2023 AUPC I AMENDMENT TO USE PROCESSING COMPLETE Loading...
Feb 22, 2023 EAAU I TEAS AMENDMENT OF USE RECEIVED Loading...
Jul 28, 2022 MDSC E NOTICE OF DESIGN SEARCH CODE E-MAILED Loading...
Jul 27, 2022 NWOS I NEW APPLICATION OFFICE SUPPLIED DATA ENTERED Loading...
Jul 12, 2022 NWAP I NEW APPLICATION ENTERED Loading...

Detailed Classifications

Class 005
pharmaceutical preparations for the treatment of kidney disease; pharmaceutical preparations for the treatment of focal segmental glomerulosclerosis (FSGS); pharmaceutical preparations for the treatment of Immunoglobulin A Nephropathy (IgAN); pharmaceutical preparations for the treatment of Alport Syndrome; pharmaceutical preparations for the treatment of glomerulonephropathy; pharmaceutical preparations for the treatment of glomerulonephritis
First Use Anywhere: Feb 17, 2023
First Use in Commerce: Feb 17, 2023

Additional Information

Design Mark
The mark consists of a circle with interlocking halves having interdigitated fingers, the left half being blue and the right half being purple.
Color Claim
The color(s) blue and purple is/are claimed as a feature of the mark.

Classification

International Classes
005